Sign in
Taking peopleNo phase

Lebanese Interhospital Pneumococcal Surveillance Program

Key facts

Who runs it
American University of Beirut Medical Center
Where
Lebanon1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
700 people, planned
Started
Oct 2005
Expected to end
Oct 2030
Type of study
Observational
Record updated
3 February 2023

Who can take part

Age
1 day and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Samples included in the study are those that are:; culture proven; invasive pneumococcal infections; in patients of all ages admitted to different hospitals all over Lebanon
  • Acceptable samples include:; positive isolates from blood; cerebrospinal fluid; other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration

Who cannot take part

  • non S. pneumoniae isolates

This trial is currently available in Lebanon.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are many types of these bacteria defined by the type of sugar coat that they have. These are classified as serotypes. There are common serotypes that cause severe disease and are preventable by vaccination of children. Other less common types are more difficult to prevent. The investigators aim to determine the serotypes that cause invasive pneumococcal disease in Lebanon and to study their sensitivity to different antibiotics. The investigators will collect bacterial isolates from different hospitals in Lebanon isolated from the blood or spinal fluid of patients with invasive pneumococcal disease. This information will help the investigators determine the usefulness of available pneumococcal vaccines in preventing these infections. The data will be distributed to all primary care physicians treating children in Lebanon and will be shared with the Ministry of Health.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Lebanese Interhospital Pneumococcal Surveillance Program (LIPSP)
Record updated
3 February 2023